Neutralization of IL-22 was shown to alleviate cardiac inflammation, reduce cardiac hypertrophy, and alleviate vascular inflammation in angiotensin II- (Ang II-) treated mice, causing decreases in their blood pressure levels [6, 7]. This evidence concerns the gene AGT and cardiac hypertrophy.